These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1559316

  • 1. [Dyslipidemia in the uremic patient: the therapeutic role played by simvastatin].
    Bellinghieri G, Angelé B, Savica V.
    Clin Ter; 1992 Jan; 140(1 Pt 2):11-6. PubMed ID: 1559316
    [Abstract] [Full Text] [Related]

  • 2. [The hypotriglyceridemic action of the combination of L-carnitine + simvastatin vs. L-carnitine and vs. simvastatin].
    Savica V, Bellinghieri G, Lamanna F.
    Clin Ter; 1992 Jan; 140(1 Pt 2):17-22. PubMed ID: 1559317
    [Abstract] [Full Text] [Related]

  • 3. Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients.
    Fiorini F, Patrone E, Castelluccio A.
    Clin Ter; 1994 Sep; 145(9):213-7. PubMed ID: 7813167
    [Abstract] [Full Text] [Related]

  • 4. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Sep; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R.
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL.
    Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 10. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
    Maher VM, Thompson GR.
    Q J Med; 1990 Feb 27; 74(274):165-75. PubMed ID: 2111917
    [Abstract] [Full Text] [Related]

  • 11. [The treatment of refractory hyperlipoproteinemias].
    Barone A, Ansuini R, Francolini G, Frausini G, Pupita F.
    Clin Ter; 1990 Oct 15; 135(1):31-6. PubMed ID: 2149540
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Feb 28; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment].
    Fiorini F, Patrone E, Ardu F, Castelluccio A.
    Minerva Urol Nefrol; 1992 Feb 28; 44(2):165-8. PubMed ID: 1411867
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
    Gavelli MS, Vitaliano E, Serra T, Rossi FG, Rizzuti A, Caridis R, Tozzi J.
    Clin Ter; 1990 May 15; 133(3):145-50. PubMed ID: 2142901
    [Abstract] [Full Text] [Related]

  • 19. [Effect of a long-term treatment with simvastatin, an inhibitor of HMG-CoA reductase, in dyslipidemic patients at high risk].
    Strano A, Novo S, Notarbartolo A, Davì G, Abrignani MG, Alaimo G, Averna MR, Barbagallo CM, Marino G.
    Cardiologia; 1989 Dec 15; 34(12):1027-33. PubMed ID: 2634479
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.